BC signs Canada's first pharmacare agreement, securing $195m for hormone therapy and diabetes expenses.

British Columbia has become Canada's first province to sign a pharmacare agreement with the federal government, securing approximately $195 million from a $1.5 billion national plan to fund hormone replacement therapy and diabetes expenses. This funding is expected to begin in April, pending legislative approval. The initiative aims to benefit around 40,000 women needing hormone therapy and support 150,000 residents on diabetes medications.

September 12, 2024
53 Articles